Alan M Hoberman insider trades: Bioxytran (BIXT) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alan reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | BIXT | ↑ Buy | 210,000 | $0.60 | $126K | Direct | Nov 18, 2025 (0d) |
| Mar 10, 2015 | BTHE | ↑ Buy | 5,000 | $0.22 | $1K | Direct | Mar 16, 2015 (6d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Alan M Hoberman's insider trades
Alan M Hoberman is a director at Bioxytran (BIXT). Since Mar 10, 2015, Alan has reported 2 open-market purchases worth $127K and no sales on SEC Form 4. In the last 12 months: 1 buy ($126K).
Their filings also include grants and awards (13 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIXT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.